The FDA has approved Bayer’s Ambelvist (gadoquatrane), the lowest-dose macrocyclic GBCA for adult and pediatric contrast-enhanced CNS and body MRI exams.

AMBELVIST ® (gadoquatrane) is a gadolinium-based contrast agent indicated in adult and pediatric patients, including term neonates, for use with magnetic resonance imaging (MRI) to detect and ...

Contrast-enhanced MRI demonstrated a sensitivity of 91.3% and a specificity of 68.8% in assessing high-risk breast lesions, with the potential to help patients avoid unnecessary surgery, according to ...

Nanoscientists have demonstrated a method for loading nanoparticles with iron ions to create MRI contrast agents that outperform gadolinium chelates, the mainstay contrast agent that is facing ...

Brain MRI without contrast agent is just as effective as the contrast-enhanced approach for monitoring disease progression in patients with multiple sclerosis (MS), according to a new study in the ...

Multiple sclerosis (MS) is a chronic disabling disease affecting over 2.8 million people worldwide, with a disproportionate impact on young populations. Magnetic resonance imaging (MRI) biomarkers are ...

You can keep your best guesses. Engineers at Rice University's George R. Brown School of Engineering are starting to understand exactly what goes on when doctors pump contrast agents into your body ...

Synthesizing brain MRI lesions is challenging due to the heterogeneity of lesion characteristics and the complexity of capturing fine-grained pathological information across MRI contrasts.

Intestinal ultrasound demonstrates strong agreement with MRI in assessing Crohn’s disease activity, supporting its use as a ...

The FDA has approved Ambelvist, a macrocyclic gadolinium-based option for contrast-enhanced MRI, now the lowest ...